Your browser doesn't support javascript.
loading
CD19+ lineage chimerism, an early biomarker after anti-CD19 CAR-T cell therapy in patients previously receiving a hematopoietic stem cell transplantation.
Martínez-Romera, Isabel; Galán-Gómez, Víctor; González-Martínez, Berta; Guerra García, Pilar; San Román Pacheco, Sonsoles; Corral Sánchez, Dolores; Mozo Del Castillo, Yasmina; Bueno Sánchez, David; Sisinni, Luisa; González Guerrero, Alba; Castellano Dámaso, Serafin; Sánchez Zapardiel, Elena; Ruz Caracuel, Beatriz; Balas Pérez, Antonio; Pérez-Martínez, Antonio.
Afiliación
  • Martínez-Romera I; Pediatric Hematology and Oncology Department, La Paz University Hospital, Madrid, Spain.
  • Galán-Gómez V; Pediatric Hematology and Oncology Department, La Paz University Hospital, Madrid, Spain.
  • González-Martínez B; Pediatric Hematology and Oncology Department, La Paz University Hospital, Madrid, Spain.
  • Guerra García P; Pediatric Hematology and Oncology Department, La Paz University Hospital, Madrid, Spain.
  • San Román Pacheco S; Pediatric Hematology and Oncology Department, La Paz University Hospital, Madrid, Spain.
  • Corral Sánchez D; Pediatric Hematology and Oncology Department, La Paz University Hospital, Madrid, Spain.
  • Mozo Del Castillo Y; Pediatric Hematology and Oncology Department, La Paz University Hospital, Madrid, Spain.
  • Bueno Sánchez D; Pediatric Hematology and Oncology Department, La Paz University Hospital, Madrid, Spain.
  • Sisinni L; Pediatric Hematology and Oncology Department, La Paz University Hospital, Madrid, Spain.
  • González Guerrero A; Pediatric Hematology and Oncology Department, La Paz University Hospital, Madrid, Spain.
  • Castellano Dámaso S; Pediatric Hematology and Oncology Department, La Paz University Hospital, Madrid, Spain.
  • Sánchez Zapardiel E; Immunology Department, La Paz University Hospital, Madrid, Spain.
  • Ruz Caracuel B; Institute of Medical and Molecular Genetics (INGEMM), La Paz University Hospital, Madrid, Spain.
  • Balas Pérez A; Center of Blood Transfusion, Madrid, Spain.
  • Pérez-Martínez A; Pediatric Hematology and Oncology Department, La Paz University Hospital, Madrid, Spain.
Front Immunol ; 13: 960412, 2022.
Article en En | MEDLINE | ID: mdl-36003375
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Inmunoterapia Adoptiva / Antígenos CD19 / Quimerismo / Receptores Quiméricos de Antígenos Tipo de estudio: Etiology_studies / Observational_studies Límite: Humans Idioma: En Revista: Front Immunol Año: 2022 Tipo del documento: Article País de afiliación: España
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Inmunoterapia Adoptiva / Antígenos CD19 / Quimerismo / Receptores Quiméricos de Antígenos Tipo de estudio: Etiology_studies / Observational_studies Límite: Humans Idioma: En Revista: Front Immunol Año: 2022 Tipo del documento: Article País de afiliación: España